detect
respiratori
virus
molecular
method
children
without
respiratori
symptom
undergo
hematopoiet
cell
transplant
hct
well
describ
prospect
studi
asymptomat
children
detect
respiratori
virus
patient
hct
human
rhinoviru
hrv
detect
patient
human
adenoviru
hadv
patient
two
addit
patient
shed
hrv
one
shed
human
coronaviru
hcov
posthct
two
patient
coinfect
asymptomat
patient
respiratori
viru
detect
later
develop
upper
respiratori
tract
infect
viru
asymptomat
shed
human
rhinoviru
hrv
human
coronaviru
hcov
document
immun
compet
children
adult
hematopoiet
cell
transplant
hct
recipi
howev
asymptomat
shed
respiratori
virus
detect
molecular
method
children
undergo
hct
well
describ
prospect
longitudin
cohort
studi
children
year
age
st
jude
children
research
hospit
sjrch
undergo
allogen
hct
januari
march
patient
enrol
regardless
presenc
absenc
symptom
upper
respiratori
tract
urti
lower
respiratori
tract
infect
lrti
prior
transplant
studi
approv
institut
review
board
consent
obtain
parentsguardian
patient
year
age
nasopharyng
wash
npw
obtain
week
prior
stem
cell
infus
everi
week
day
patient
prehct
sampl
consid
evalu
follow
prospect
day
patient
evalu
symptom
sign
urti
lrti
week
period
prior
first
wash
total
nucleic
acid
extract
origin
sampl
day
use
biomerieux
minimag
easymag
extract
system
durham
nc
store
c
batch
analyz
regular
interv
molecular
test
perform
use
multicodeplx
respiratori
pcr
panel
eragen
bioscienc
madison
wi
nucleic
acid
underw
revers
transcript
pcr
captur
use
bead
attach
probe
target
influenza
influenza
b
parainfluenza
viru
respiratori
syncyti
viru
rsv
human
adenoviru
hadv
human
metapneumoviru
enteroviru
hrv
hcov
reaction
product
hybrid
microspherebas
array
analyz
benchtop
flowcel
luminex
corpor
austin
tx
assay
shown
analyt
limit
detect
copi
per
reaction
use
clone
target
sequenc
assay
respiratori
virus
sensit
clinic
sampl
exceed
convent
cultur
antigen
detect
method
routin
detect
respiratori
virus
symptomat
patient
sjcrh
took
place
use
panel
individu
realtim
pcr
assay
clinic
assay
target
hadv
influenza
influenza
b
human
metapneumoviru
parainfluenza
viru
rsv
npw
symptomat
patient
studi
test
use
clinic
researchbas
assay
data
clinic
assay
includ
research
studi
physician
blind
data
research
studi
infect
defin
detect
respiratori
viru
associ
urti
lrti
day
infect
onset
defin
day
sampl
collect
correspond
first
posit
diagnost
test
durat
viral
shed
time
day
collect
first
posit
first
neg
test
preval
respiratori
viru
shed
day
first
sampl
collect
prehct
exact
confid
interv
base
binomi
distribut
provid
associ
transplantrel
variabl
respiratori
viru
shed
studi
framework
cox
proport
hazard
model
analys
perform
first
episod
respiratori
viru
shed
transplantrel
variabl
abstract
prospect
collect
databas
sa
version
sa
institut
cari
nc
use
statist
analys
total
elig
asymptomat
patient
approach
consent
studi
particip
eighti
two
sampl
collect
patient
patient
baselin
sampl
collect
prehct
refus
sampl
owe
unpleas
sensat
salin
nasopharynx
median
rang
sampl
collect
remain
patient
mean
age
rang
year
twenti
patient
male
white
compris
major
acut
leukemia
common
diagnosi
fourteen
patient
haploident
hct
patient
underw
hct
matchedunrel
donor
total
bodi
irradi
given
patient
twelv
patient
acut
graftvshost
diseas
none
patient
histori
prior
respiratori
ill
week
prior
hct
hrv
detect
patient
hadv
patient
baselin
sampl
prehct
two
addit
patient
shed
hrv
one
shed
posthct
figur
day
preval
respiratori
viru
exact
ci
preval
hrv
exact
ci
two
patient
coinfect
hrv
hadv
hadv
rsv
posthct
coxproport
hazard
model
show
relationship
transplant
variabl
respiratori
viru
detect
patient
respiratori
viru
detect
follow
sampl
obtain
patient
median
rang
week
three
patient
shed
viru
week
shed
week
figur
two
patient
develop
urti
hrv
day
onset
asymptomat
hrv
shed
straintyp
hrv
perform
urti
symptom
develop
one
week
detect
asymptomat
patient
urti
resolv
without
progress
respiratori
advers
outcom
nosocomi
outbreak
note
hrv
describ
associ
lrti
adult
hct
recipi
prospect
longitudin
surveil
studi
asymptomat
shed
hrv
seen
adult
hct
patient
hrv
detect
patient
sixth
patient
viral
shed
last
week
asymptomat
shed
hrv
common
childhood
recipi
hct
seri
viral
shed
last
longer
hcov
also
note
associ
lrti
adult
hct
recipi
asymptomat
shed
hcov
seen
adult
hct
patient
median
durat
viral
shed
patient
week
use
npw
shown
increas
sensit
detect
respiratori
virus
compar
nasal
swab
howev
children
accept
npw
well
account
patient
either
declin
particip
studi
withdrew
first
sampl
small
number
patient
preclud
correl
urti
durat
shed
transplant
associ
variabl
limit
abil
draw
conclus
implic
asymptomat
detect
respiratori
viru
transplant
set
underscor
need
subsequ
studi
sequenti
collect
sampl
determin
cours
asymptomat
shed
hct
patient
studi
advantag
prospect
demonstr
asymptomat
shed
respiratori
virus
use
molecular
method
pediatr
hct
patient
infer
causal
base
detect
hrv
hcov
symptomat
hct
patient
made
caution
sinc
virus
shed
detect
asymptomat
patient
futur
studi
use
quantit
detect
approach
viral
load
cutoff
determin
children
asymptomat
shed
prior
transplant
predispos
develop
symptomat
diseas
warrant
may
implic
infect
control
pediatr
hct
unit
patient
human
rhinoviru
hrv
human
adenoviru
hadv
respiratori
syncyti
viru
rsv
human
coronaviru
hcov
detect
week
first
nasal
wash
pretranspl
week
first
wash
follow
sampl
wash
done
viru
detect
shown
neg
